Resource topic
Research
Explore research explainers on mental health, addiction, treatment and access to care. These articles look at what studies found, how the evidence was gathered and which limitations matter when interpreting the results. The collection helps readers distinguish promising findings from established knowledge without presenting research summaries as personal treatment recommendations.
YOU MAY FIND THESE HELPFUL
Start here.
High Performance Is Not a Health Assessment, and a…
ExploreRead & learnA Medal Is Not a Mental-Health Assessment
ExploreRead & learnLuxury Is Not an Outcome
ExploreAssessment & Treatment Planning
ExplorePlan your stayHow Admission Works
ExploreRead & learnHigh Performance Is Not a Health Assessment, and a…
ExploreHow it connects
Presentation before label
Symptoms are understood in context, including overlap and co-occurring needs.
- 01History
- 02Current safety
- 03Patterns
- 04Needs
Clinical resource
One Dose, One Year Later: The Psilocybin Results That Complicate the Breakthrough Story
Two European trials published in 2026 found different answers at different endpoints. German primary-response results and Swedish one-year follow-up show why rapid improvement is…
Read →Clinical resource
Ten Minutes Is Not a Treatment Plan: What the New DMT Trial Really Measures
A UK-led DMT trial reported a positive two-week depression result. Its brief administration, controlled phase and longer open-label follow-up are different parts of the…
Read →Clinical resource
A Faster Schedule Is Not Proof of a Better Treatment: The New TMS Evidence
Two 2026 stimulation trials asked different questions. One supported a compressed schedule against standard treatment; another found no significant advantage over sham despite personalized…
Read →Clinical resource
The Diet Study Has Two Timelines. Only One Was Randomized.
A 2026 ketogenic-diet trial strengthens the metabolic evidence while leaving psychiatric durability questions open. Its one-month randomized comparison and four-month extension should not be…
Read →Clinical resource
A Brain Scan Can Classify a Pattern. Can It Choose Your Treatment?
A six-biotype depression study offers a promising research framework. It does not, by itself, establish that buying a scan will produce a better treatment…
Read →Clinical resource
59 Candidates, Two Starting Arms: Europe’s Next Depression Breakthrough May Be a Better Trial
EU-PEARLDIVER proposes a shared European platform for testing depression treatments. Its significance is a plan for stronger comparisons, not evidence that the selected drugs…
Read →Clinical resource
Two Specialists. One Patient: Bahrain’s Physical and Mental-Health Coordination Question
Newly published Bahrain research links reported physical symptoms with academic disruption, while local treatment findings remain preliminary. What should coordinated private care actually demonstrate?
Read →Clinical resource
Oman Is Adding Addiction-Treatment Capacity. What Happens After Discharge?
Oman's new rehabilitation capacity raises a question relevant to families choosing care locally or abroad: who measures recovery after the residential stay?
Read →Clinical resource
One Gulf, Six Different Measures: Why More Mental-Health Care Is Not Yet a Comparable Recovery Story
A six-country examination of Gulf mental-health evidence: consultations, workforce, screening, student studies and rehabilitation capacity answer different questions about care and recovery.
Read →Clinical resource
Europe’s Prescription Divide: More Medication Is Not a Recovery League Table
Antidepressant consumption differs sharply across European countries. A comparison of OECD prescribing and patient-reported data explains why medication volume cannot rank recovery.
Read →Clinical resource
More Access Is Not the Same as Recovery: The Global Mental-Health Gap That Wealth Alone Cannot Measure
Global depression-treatment estimates, a 2026 quality-of-care study and WHO system indicators expose three different gaps: reaching care, receiving an appropriate pathway and measuring whether…
Read →Clinical resource
The Chatbot Beat a Waiting List. It Did Not Beat a Therapist.
The Therabot trial offers promising symptom findings, but not a head-to-head comparison with human therapy. For private and internationally mobile patients, availability, privacy and…
Read →